Literature DB >> 807545

Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization.

C Coronelli, R J White, G C Lancini, F Parenti.   

Abstract

Lipiarmycin, a metabolite of Actinoplanes deccanensis nov. sp. (PARENTI et al.), has been isolated in pure form. It has a molecular formula C52 CONGRUENT TO 54H74 CONGRUENT TO 76Cl2O19, (M.W. = 1,073 CONGRUENT TO 1,099). From its chemical and physico-chemical characteristics, lipiarmycin can be considered a new antibiotic. Lipiarmycin is highly active against Gram-positive bacteria, including strains resistant to the medically important antibiotics and protects mice experimentally infected with Streptococcus haemolyticus. Liparmycin inhibits growth of susceptible bacteria by interfering with RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807545     DOI: 10.7164/antibiotics.28.253

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  23 in total

1.  The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site.

Authors:  Audrey Tupin; Maxime Gualtieri; Jean-Paul Leonetti; Konstantin Brodolin
Journal:  EMBO J       Date:  2010-06-18       Impact factor: 11.598

Review 2.  Bacterial Transcription as a Target for Antibacterial Drug Development.

Authors:  Cong Ma; Xiao Yang; Peter J Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2016-01-13       Impact factor: 11.056

Review 3.  Genetics of antibiotic production.

Authors:  D A Hopwood; M J Merrick
Journal:  Bacteriol Rev       Date:  1977-09

Review 4.  Natural Products as Platforms To Overcome Antibiotic Resistance.

Authors:  Sean E Rossiter; Madison H Fletcher; William M Wuest
Journal:  Chem Rev       Date:  2017-09-27       Impact factor: 60.622

Review 5.  Astonishing diversity of natural surfactants: 2. Polyether glycosidic ionophores and macrocyclic glycosides.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2005-03       Impact factor: 1.880

Review 6.  Mechanistic aspects of promoter binding and chain initiation by RNA polymerase.

Authors:  C W Wu; N Tweedy
Journal:  Mol Cell Biochem       Date:  1982-09-17       Impact factor: 3.396

7.  Inhibition by lipiarmycin of bacteriophage growth in Bacillus subtilis.

Authors:  M S Osburne; A L Sonenshein
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

Review 8.  Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.

Authors:  Kathleen Mullane
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

9.  In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile.

Authors:  R N Swanson; D J Hardy; N L Shipkowitz; C W Hanson; N C Ramer; P B Fernandes; J J Clement
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

10.  Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea.

Authors:  Yoav Golan; Lauren Epstein
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.